检索结果 - Arjun Law
- Showing 1 - 4 results of 4
-
1
-
2
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy 由 Brent A. Williams, Arjun Law, Bertrand Routy, Neal denHollander, Vikas Gupta, Xinghua Wang, A. Chaboureau, Sowmya Viswanathan, Armand Keating
出版 2017Artigo -
3
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploi... 由 Arjun Law, María Queralt Salas, Wilson Lam, Fotios V. Michelis, Santhosh Thyagu, Dennis Dong Hwan Kim, Jeffrey H. Lipton, Rajat Kumar, Hans A. Messner, Auro Viswabandya
出版 2018Artigo -
4
Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD 由 Jongbok Lee, Hyeonjeong Kang, Branson Chen, Yoosu Na, Ismat Khatri, Fraser Soares, Housheng Hansen He, Arjun Law, Tianzhong Pan, Armin Gerbitz, Xiaoyu Zhu, Mark D. Minden, Li Zhang
出版 2025Artigo
相关主题
Immunology
Medicine
Biology
Hematopoietic stem cell transplantation
Internal medicine
Transplantation
Cancer research
Gastroenterology
Graft-versus-host disease
Immune system
Myeloid leukemia
Stem cell
Anti-thymocyte globulin
Antibody
Antibody-dependent cell-mediated cytotoxicity
Astrobiology
Busulfan
CD33
CD34
CD8
Cell biology
Chemotherapy
Chills
Clinical trial
Cumulative incidence
Cyclophosphamide
Cytarabine
Fludarabine
Genetics
Haematopoiesis